VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PMCB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PMCBPharmaCyte Biotech, Inc.
$0.77$8M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPMCBPrice History

PMCB logoPharmaCyte Biotech, Inc. (PMCB) Stock Price History

Historical prices from 2013 to 2026

$0.77+0.01  (+1.44%)close Jun 26
Returns
1M
-2.0%
3M
-1.3%
YTD
+4.3%
1Y
-26.7%
3Y
-35.6%
5Y
-46.4%
ATH$961.00Feb 2014-99.9%
ATL$0.63Mar 2026pre-split
Avg Vol (50D)189K/ day
52-Week Range$0.63 — $1.51
LowCurrent: $0.77High

Loading 10-year price history...

PMCB Historical Performance

1 YearTotal Return
-27.5%
Price: -26.7%
3 YearsTotal Return
-73.3%
CAGR: -35.6%
Price: -73.3%
5 YearsTotal Return
-96.3%
CAGR: -48.2%
Price: -95.6%
YTD
+4.3%

PMCB Annual Returns

Year-by-year price performance · 2013–2026

Best+175.7%2013
Worst-83.6%2020
Up years5/14
2013+175.7%
2014+57.2%
2015-76.0%
2016+163.5%
2017-61.0%
2018-39.3%
2019+3.6%
2020-83.6%
2021-78.5%
2022+5.8%
2023-26.3%
2024-28.3%
2025-55.9%
2026-6.5%
2013 annual price return
+175.7%
2014 annual price return
+57.2%
2015 annual price return
-76.0%
2016 annual price return
+163.5%
2017 annual price return
-61.0%
2018 annual price return
-39.3%
2019 annual price return
+3.6%
2020 annual price return
-83.6%
2021 annual price return
-78.5%
2022 annual price return
+5.8%
2023 annual price return
-26.3%
2024 annual price return
-28.3%
2025 annual price return
-55.9%
2026 annual price return
-6.5%
LessMore
Alpha vs S&P 500
1Y-48.4%
3Y-55.4%
5Y-58.5%

Price returns only.

Download Historical Data

3,392 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

PMCB Stock Price Trajectory (2013–2026)

As of June 29, 2026, PharmaCyte Biotech, Inc. (PMCB) trades at $0.77, representing a -26.7% return over the past year. The stock has delivered a -96.3% total return over five years (-46.4% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $961.00 on February 28, 2014. From this peak, PMCB has corrected -99.9%, currently trading 6% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers NKTR (+114.5% 1Y), SNGX (-70.1% 1Y), and AGEN (-38.3% 1Y), PMCB has underperformed the peer group average. Compare PMCB vs NKTR →

PMCB Historical Price Data · from 2013

Rows 1–50 of 3,392
Date Open High Low Close Volume Change %
2026-06-260.730.780.720.7733K+1.44%
2026-06-250.770.790.730.7675K-1.20%
2026-06-240.760.770.750.7718K-1.07%
2026-06-230.770.800.760.7878K+1.07%
2026-06-220.720.800.710.77156K+3.10%
2026-06-180.780.800.730.74161K-5.36%
2026-06-170.800.820.780.7977K-4.93%
2026-06-160.790.840.780.83149K+2.16%
2026-06-150.770.840.770.81133K+6.50%
2026-06-120.760.810.760.76170K+1.45%
2026-06-110.700.780.700.75190K+7.16%
2026-06-100.710.720.700.7032K0.00%
2026-06-090.700.710.700.7063K0.00%
2026-06-080.710.720.680.70234K0.00%
2026-06-050.720.740.670.704K-3.50%
2026-06-040.710.750.710.7351K-0.17%
2026-06-030.720.750.700.7384K-3.27%
2026-06-020.780.810.750.75128K-6.11%
2026-06-010.830.840.790.8090K-4.11%
2026-05-290.850.850.820.83139K-2.67%
2026-05-280.760.860.760.86394K+12.80%
2026-05-270.780.780.760.7679K-3.26%
2026-05-260.800.810.770.79125K-3.01%
2026-05-220.790.860.770.81550K+1.75%
2026-05-210.780.830.770.80257K+3.63%
2026-05-200.750.810.700.77237K+4.95%
2026-05-190.780.800.730.73208K-3.68%
2026-05-180.790.830.760.76155K-5.52%
2026-05-150.940.940.760.80475K-15.38%
2026-05-140.830.960.790.951.76M+17.07%
2026-05-130.770.850.740.81458K+2.78%
2026-05-120.710.830.700.79833K+13.69%
2026-05-110.750.770.670.69182K-8.06%
2026-05-080.760.800.740.7657K-5.53%
2026-05-070.740.810.740.8093K+3.90%
2026-05-060.740.780.720.77136K+5.05%
2026-05-050.750.760.720.7356K-3.55%
2026-05-040.770.780.740.7686K+0.62%
2026-05-010.750.760.750.7674K+4.61%
2026-04-300.760.780.720.72106K-3.73%
2026-04-290.750.780.750.7520K-1.32%
2026-04-280.750.780.750.7648K-0.35%
2026-04-270.740.780.740.76132K+5.59%
2026-04-240.770.770.720.7252K-3.68%
2026-04-230.780.780.740.7555K-3.87%
2026-04-220.750.790.740.78125K+1.31%
2026-04-210.750.770.730.77101K+0.79%
2026-04-200.750.770.700.76169K+4.86%
2026-04-170.730.740.720.7353K+0.12%
2026-04-160.740.770.710.73229K-4.44%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PMCB — Frequently Asked Questions

Quick answers to the most common questions about buying PMCB stock.

How has PMCB stock performed recently?

PMCB declined -26.7% over the past year, below its 5-year annualized CAGR of -46.4%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is PMCB's all-time high price?

PharmaCyte Biotech, Inc. reached $961.00 on 2014-02-28. The 52-week high is $1.51. Current 1-year return of -26.7% places the stock further from historical peaks.

Where can I download PMCB historical price data?

This page provides PMCB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2013-2026, downloadable in CSV format.

486 data points · sampled from 3,392